| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF35 ZNF442 HEY2 ZNF564 ZNF14 ZNF93 ZNF251 ZFHX3 ELF5 PRMT5 ZNF83 | 1.82e-07 | 1459 | 23 | 11 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 1.42e-05 | 1412 | 23 | 9 | GO:0000981 | |
| GeneOntologyMolecularFunction | TAP complex binding | 4.55e-05 | 9 | 23 | 2 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 4.55e-05 | 9 | 23 | 2 | GO:0042610 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 4.68e-05 | 1244 | 23 | 8 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 5.46e-05 | 1271 | 23 | 8 | GO:0000987 | |
| GeneOntologyMolecularFunction | TAP1 binding | 5.68e-05 | 10 | 23 | 2 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 5.68e-05 | 10 | 23 | 2 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 5.68e-05 | 10 | 23 | 2 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 8.32e-05 | 12 | 23 | 2 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.71e-04 | 17 | 23 | 2 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 2.38e-04 | 20 | 23 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 4.51e-04 | 320 | 23 | 4 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 4.83e-04 | 326 | 23 | 4 | GO:0001217 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 6.16e-04 | 32 | 23 | 2 | GO:0042288 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.06e-03 | 42 | 23 | 2 | GO:0071889 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.44e-03 | 49 | 23 | 2 | GO:0042605 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 1.98e-03 | 1205 | 23 | 6 | GO:0046983 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.02e-03 | 58 | 23 | 2 | GO:0042287 | |
| GeneOntologyMolecularFunction | peptide binding | 5.60e-03 | 318 | 23 | 3 | GO:0042277 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 2.96e-05 | 163 | 23 | 4 | GO:0002456 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 3.32e-05 | 8 | 23 | 2 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.41e-04 | 16 | 23 | 2 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.60e-04 | 17 | 23 | 2 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.60e-04 | 17 | 23 | 2 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.80e-04 | 18 | 23 | 2 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.80e-04 | 18 | 23 | 2 | GO:0042590 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 2.48e-04 | 111 | 23 | 3 | GO:0002709 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression via chromosomal CpG island methylation | 2.97e-04 | 23 | 23 | 2 | GO:0044027 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 2.97e-04 | 23 | 23 | 2 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 3.51e-04 | 25 | 23 | 2 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 3.51e-04 | 25 | 23 | 2 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 5.78e-04 | 32 | 23 | 2 | GO:0019883 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 6.00e-04 | 150 | 23 | 3 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 9.38e-04 | 175 | 23 | 3 | GO:0002705 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 9.50e-04 | 41 | 23 | 2 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 9.97e-04 | 42 | 23 | 2 | GO:0001916 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.30e-03 | 48 | 23 | 2 | GO:0002478 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 1.41e-03 | 449 | 23 | 4 | GO:0002449 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.57e-03 | 462 | 23 | 4 | GO:0002460 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 1.58e-03 | 53 | 23 | 2 | GO:0001914 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.42e-05 | 7 | 23 | 2 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 5.18e-05 | 10 | 23 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 1.05e-04 | 14 | 23 | 2 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.56e-04 | 17 | 23 | 2 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 2.89e-04 | 23 | 23 | 2 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 3.70e-04 | 26 | 23 | 2 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 6.74e-04 | 35 | 23 | 2 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 9.71e-04 | 42 | 23 | 2 | GO:0070971 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.27e-03 | 48 | 23 | 2 | GO:0098576 | |
| GeneOntologyCellularComponent | recycling endosome | 1.79e-03 | 222 | 23 | 3 | GO:0055037 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 2.24e-03 | 64 | 23 | 2 | GO:0012507 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 3.73e-03 | 83 | 23 | 2 | GO:0030670 | |
| GeneOntologyCellularComponent | cis-Golgi network | 3.91e-03 | 85 | 23 | 2 | GO:0005801 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 6.46e-03 | 110 | 23 | 2 | GO:0030134 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 6.69e-03 | 112 | 23 | 2 | GO:0055038 | |
| GeneOntologyCellularComponent | membrane raft | 7.05e-03 | 362 | 23 | 3 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 7.16e-03 | 364 | 23 | 3 | GO:0098857 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 8.27e-03 | 125 | 23 | 2 | GO:0140534 | |
| GeneOntologyCellularComponent | endocytic vesicle | 8.29e-03 | 384 | 23 | 3 | GO:0030139 | |
| GeneOntologyCellularComponent | Golgi cisterna | 9.58e-03 | 135 | 23 | 2 | GO:0031985 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.22e-02 | 443 | 23 | 3 | GO:0098791 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 1.28e-02 | 157 | 23 | 2 | GO:0045335 | |
| GeneOntologyCellularComponent | lysosomal membrane | 1.37e-02 | 462 | 23 | 3 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 1.37e-02 | 462 | 23 | 3 | GO:0098852 | |
| GeneOntologyCellularComponent | Golgi stack | 1.50e-02 | 171 | 23 | 2 | GO:0005795 | |
| MousePheno | spinal cord inflammation | 3.88e-05 | 8 | 17 | 2 | MP:0030987 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.69e-07 | 775 | 23 | 9 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.72e-07 | 777 | 23 | 9 | PS00028 | |
| Domain | Znf_C2H2-like | 2.11e-07 | 796 | 23 | 9 | IPR015880 | |
| Domain | Znf_C2H2 | 2.33e-07 | 805 | 23 | 9 | IPR007087 | |
| Domain | ZnF_C2H2 | 2.40e-07 | 808 | 23 | 9 | SM00355 | |
| Domain | - | 8.84e-07 | 679 | 23 | 8 | 3.30.160.60 | |
| Domain | zf-C2H2 | 1.03e-06 | 693 | 23 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.04e-06 | 694 | 23 | 8 | IPR013087 | |
| Domain | MHC_I_a_C | 2.17e-05 | 6 | 23 | 2 | IPR010579 | |
| Domain | MHC_I_C | 2.17e-05 | 6 | 23 | 2 | PF06623 | |
| Domain | zf-C2H2_6 | 3.41e-05 | 314 | 23 | 5 | PF13912 | |
| Domain | KRAB | 6.37e-05 | 358 | 23 | 5 | PS50805 | |
| Domain | KRAB | 6.37e-05 | 358 | 23 | 5 | PF01352 | |
| Domain | KRAB | 7.35e-05 | 369 | 23 | 5 | SM00349 | |
| Domain | KRAB | 7.45e-05 | 370 | 23 | 5 | IPR001909 | |
| Domain | MHC_I_a_a1/a2 | 3.00e-04 | 21 | 23 | 2 | IPR001039 | |
| Domain | MHC_I | 3.00e-04 | 21 | 23 | 2 | PF00129 | |
| Domain | C1-set | 2.00e-03 | 54 | 23 | 2 | PF07654 | |
| Domain | IGc1 | 2.15e-03 | 56 | 23 | 2 | SM00407 | |
| Domain | Ig_C1-set | 2.30e-03 | 58 | 23 | 2 | IPR003597 | |
| Domain | Ig/MHC_CS | 2.30e-03 | 58 | 23 | 2 | IPR003006 | |
| Domain | IG_MHC | 2.46e-03 | 60 | 23 | 2 | PS00290 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 4.90e-05 | 9 | 17 | 2 | MM14527 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.89e-04 | 768 | 17 | 6 | MM14851 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 2.07e-04 | 18 | 17 | 2 | MM14525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 2.57e-04 | 20 | 17 | 2 | MM1374 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 4.04e-04 | 25 | 17 | 2 | MM1465 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 4.04e-04 | 25 | 17 | 2 | MM15713 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 7.03e-04 | 1387 | 17 | 7 | M734 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 8.83e-04 | 1022 | 17 | 6 | MM15436 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.89e-03 | 54 | 17 | 2 | MM14871 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 2.03e-03 | 56 | 17 | 2 | MM17236 | |
| Pathway | WP_TAR_SYNDROME | 2.56e-03 | 63 | 17 | 2 | M48082 | |
| Pubmed | A nucleotide deletion in exon 4 is responsible for an HLA-A null allele (A*0105N). | 4.56e-07 | 2 | 24 | 2 | 10519371 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 1348042 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 6088985 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 1686840 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 1705528 | ||
| Pubmed | Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL. | 9.56e-06 | 7 | 24 | 2 | 10023770 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 6143316 | ||
| Pubmed | Manufacture of a functional cDNA for the H-2Db molecule using a retroviral shuttle vector. | 9.56e-06 | 7 | 24 | 2 | 1713192 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 2808323 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 9770513 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 7225204 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 21088134 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 9.56e-06 | 7 | 24 | 2 | 19346486 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 34181639 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 69663 | ||
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 9.56e-06 | 7 | 24 | 2 | 18383043 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 8206527 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 16272298 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 9.56e-06 | 7 | 24 | 2 | 12459592 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 19195028 | ||
| Pubmed | Tissue-specific expression of an unusual H-2 (class I)-related gene. | 9.56e-06 | 7 | 24 | 2 | 6956903 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 8833240 | ||
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 9.56e-06 | 7 | 24 | 2 | 6264319 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 21178009 | ||
| Pubmed | Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. | 9.56e-06 | 7 | 24 | 2 | 6604582 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 6815535 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 3456611 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 15809355 | ||
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 9.56e-06 | 7 | 24 | 2 | 2714856 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 10500200 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 16473882 | ||
| Pubmed | Isolation of a cDNA clone for the murine transplantation antigen H-2Kb. | 9.56e-06 | 7 | 24 | 2 | 6954478 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 16210630 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 10479061 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 12902470 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 9.56e-06 | 7 | 24 | 2 | 2391419 | |
| Pubmed | Optimized tetramer analysis reveals Ly49 promiscuity for MHC ligands. | 9.56e-06 | 7 | 24 | 2 | 24154624 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 34525366 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 3838699 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 1740659 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 3374494 | ||
| Pubmed | Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. | 9.56e-06 | 7 | 24 | 2 | 3840195 | |
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 9.56e-06 | 7 | 24 | 2 | 3025084 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 2543831 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 15671142 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 14215561 | ||
| Pubmed | Tolerance and MHC restriction in transgenic mice expressing a MHC class I gene in erythroid cells. | 9.56e-06 | 7 | 24 | 2 | 1540549 | |
| Pubmed | Structural relationships among the H-2 D-regions of murine MHC haplotypes. | 9.56e-06 | 7 | 24 | 2 | 2909618 | |
| Pubmed | Mouse histocompatibility genes: structure and organisation of a Kd gene. | 9.56e-06 | 7 | 24 | 2 | 11894934 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 19700752 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 9.56e-06 | 7 | 24 | 2 | 28234229 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 11894963 | ||
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 9.56e-06 | 7 | 24 | 2 | 6242891 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 16836618 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 22287714 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 17512611 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 3997208 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 2989712 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 3263465 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 7018573 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 9.56e-06 | 7 | 24 | 2 | 1280760 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 2997361 | ||
| Pubmed | Expression of GM1 and GD1a in mouse liver is linked to the H-2 complex on chromosome 17. | 9.56e-06 | 7 | 24 | 2 | 6671979 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 9.56e-06 | 7 | 24 | 2 | 6786753 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 6583704 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 18974374 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 8168857 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 20534453 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 6571712 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 9869916 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 16148128 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 9222352 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 12006653 | ||
| Pubmed | CD8+ T cells require perforin to clear West Nile virus from infected neurons. | 9.56e-06 | 7 | 24 | 2 | 16352536 | |
| Pubmed | The role of the MHC on resistance to group a streptococci in mice. | 9.56e-06 | 7 | 24 | 2 | 16148132 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 3199070 | ||
| Pubmed | Expression of H-2K major histocompatibility antigens on preimplantation mouse embryos. | 9.56e-06 | 7 | 24 | 2 | 8481472 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 1699529 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 312902 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 2642506 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 9037062 | ||
| Pubmed | A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. | 9.56e-06 | 7 | 24 | 2 | 15520861 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 17982076 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 19342630 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 7520098 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 1840571 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 16476767 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 16148097 | ||
| Pubmed | Serological analysis of H-2 mutations using monoclonal antibodies. | 9.56e-06 | 7 | 24 | 2 | 6084033 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 20957233 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 1329034 | ||
| Pubmed | DNA sequence of a gene encoding a BALB/c mouse Ld transplantation antigen. | 9.56e-06 | 7 | 24 | 2 | 7058332 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 15644207 | ||
| Pubmed | How a single T cell receptor recognizes both self and foreign MHC. | 9.56e-06 | 7 | 24 | 2 | 17418792 | |
| Pubmed | Inactivation of the H-2Klk gene could involve the substitutions of methylated CpGs. | 9.56e-06 | 7 | 24 | 2 | 2212699 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 9185075 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 11580250 | ||
| Pubmed | Complete nucleotide sequence of the murine H-2Kk gene. Comparison of three H-2K locus alleles. | 9.56e-06 | 7 | 24 | 2 | 6096831 | |
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 9.56e-06 | 7 | 24 | 2 | 11086076 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 24101547 | ||
| Cytoband | 19p13.2 | 6.36e-03 | 229 | 24 | 2 | 19p13.2 | |
| Cytoband | 6p21.3 | 7.53e-03 | 250 | 24 | 2 | 6p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 8.04e-03 | 797 | 24 | 3 | chr19p13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.24e-09 | 718 | 18 | 9 | 28 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 8.64e-04 | 44 | 18 | 2 | 588 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 8.87e-07 | 21 | 24 | 3 | MM651 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 7.03e-06 | 41 | 24 | 3 | MM710 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 9.57e-05 | 16 | 24 | 2 | MM3766 | |
| Coexpression | CAHOY_ASTROCYTIC | 1.03e-04 | 100 | 24 | 3 | M2806 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 1.36e-04 | 19 | 24 | 2 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 1.36e-04 | 19 | 24 | 2 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.51e-04 | 20 | 24 | 2 | MM3682 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VALVE_CELL_AGEING | 2.04e-04 | 126 | 24 | 3 | MM3709 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 2.19e-04 | 24 | 24 | 2 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 2.38e-04 | 25 | 24 | 2 | MM672 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP | 2.54e-04 | 644 | 24 | 5 | M34026 | |
| Drug | valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A | 4.23e-05 | 197 | 23 | 4 | 6408_DN | |
| Drug | ahz | 4.75e-04 | 32 | 23 | 2 | CID000656929 | |
| Drug | dibenzothiophene | 5.69e-04 | 35 | 23 | 2 | CID000003023 | |
| Drug | ceric oxide | 7.07e-04 | 39 | 23 | 2 | ctd:C030583 | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 8.96e-04 | 190 | 23 | 3 | 2869_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 5384_DN | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 4335_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 6173_UP | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; HL60; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 2168_DN | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 4814_UP | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 3135_DN | |
| Drug | Trapidil [15421-84-8]; Down 200; 19.4uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3136_DN | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; PC3; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4656_DN | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 1uM; PC3; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3826_UP | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2443_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 1151_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4359_DN | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 6782_DN | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4624_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 1511_DN | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 5766_DN | |
| Drug | Betulin [473-98-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 3513_UP | |
| Drug | resorcinol | 9.94e-04 | 197 | 23 | 3 | ctd:C031389 | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 4986_DN | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 6805_DN | |
| Drug | Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 7411_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HG-U133A | 9.94e-04 | 197 | 23 | 3 | 121_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2761_UP | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 1468_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 3216_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 2106_UP | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 4841_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; HL60; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 2542_DN | |
| Drug | Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 7166_DN | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 4252_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 4551_DN | |
| Drug | CP-645525-01 [287190-82-3]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 7515_UP | |
| Drug | haloperidol; Up 200; 10uM; HL60; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 6163_UP | |
| Drug | Dydrogesterone [152-62-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 4836_UP | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; PC3; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 6702_UP | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 3259_DN | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 4536_DN | |
| Disease | glycoprotein measurement | 1.07e-04 | 119 | 23 | 3 | EFO_0004555 | |
| Disease | serum IgE measurement | 1.14e-03 | 64 | 23 | 2 | EFO_0004579 | |
| Disease | obsolete aging | 1.29e-03 | 279 | 23 | 3 | GO_0007568 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.52e-03 | 74 | 23 | 2 | DOID:3748 (is_marker_for) | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 1.99e-03 | 85 | 23 | 2 | EFO_0000708, EFO_0006953 | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 3.31e-03 | 110 | 23 | 2 | EFO_0003095, MONDO_0005148 | |
| Disease | lymphocyte measurement | 3.73e-03 | 117 | 23 | 2 | EFO_0803546 | |
| Disease | prostate carcinoma | 4.63e-03 | 891 | 23 | 4 | EFO_0001663 | |
| Disease | basophil count | 6.05e-03 | 483 | 23 | 3 | EFO_0005090 | |
| Disease | nasopharyngeal neoplasm | 6.13e-03 | 151 | 23 | 2 | EFO_0004252 | |
| Disease | colorectal cancer (is_marker_for) | 6.61e-03 | 157 | 23 | 2 | DOID:9256 (is_marker_for) | |
| Disease | brain measurement, neuroimaging measurement | 8.64e-03 | 550 | 23 | 3 | EFO_0004346, EFO_0004464 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HTRILTLSHMHTHAH | 106 | Q6ZRP5 | |
| CTLTSTITHMHTHTH | 161 | Q6ZRP5 | |
| TLTLTHTHMHTFLSL | 186 | Q6ZRP5 | |
| HTHMHTFLSLVSHLA | 191 | Q6ZRP5 | |
| HSHRVMLDSVTHSTF | 6 | Q9UKW6 | |
| THMTHHPISDHEATL | 211 | P01893 | |
| MVHSLLHRLSHNDHI | 126 | Q5JQC4 | |
| AAAMTSSMAHHHHPL | 166 | Q9UBP5 | |
| TAHQHIYTHMSHFIK | 746 | P27487 | |
| LHMANTILPHSHSHH | 431 | Q6R327 | |
| HLHLSSHHLESGARM | 331 | Q9H5Z6 | |
| RVLTNHIHTGHHSSM | 136 | O14744 | |
| THMTHHPISDHEATL | 211 | P04439 | |
| HCLKMLLSDFSHHHI | 686 | Q9HAU5 | |
| VMCHALSHLHAMLHT | 146 | Q15612 | |
| VFMHHSSLSRHIRSH | 111 | Q8TBZ8 | |
| FHLSTHLTTHKILHT | 546 | P35789 | |
| FISNSHLMRHHRTHL | 511 | P13682 | |
| EMESLSARHSHSHHT | 531 | Q8N2C7 | |
| TSPSQRLMSTHHHHH | 1356 | O15014 | |
| HLTTSITTLNHLHML | 141 | Q5VIR6 | |
| LSHHSSFRSHMIMHT | 386 | Q9H7R0 | |
| FTHSSNLVLHHHIHT | 246 | Q9BRH9 | |
| AQFHLHFSSLHHILM | 111 | Q92748 | |
| HFSSLHHILMHLTEK | 116 | Q92748 | |
| FSMRSSLTNHHAIHT | 466 | P51522 | |
| DFIHHSSLNRHMRSH | 111 | P17017 | |
| SFVTHAVHDHRMTLS | 296 | Q15911 | |
| TLDMHHRHHLHYTSR | 486 | B0I1T2 |